O'Dowd Hugh 4
4 · Neon Therapeutics, Inc. · Filed Mar 1, 2019
Insider Transaction Report
Form 4
O'Dowd Hugh
DirectorPresident & CEO
Transactions
- Award
Common Stock
2019-02-27+100,000→ 545,868 total - Award
Stock Option (Right to Buy)
2019-02-27+200,000→ 200,000 totalExercise: $6.13Exp: 2029-02-26→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]Mr. O'Dowd was awarded 100,000 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. The Restricted Stock Units shall vest annually over three years, with one-third vesting on the last day of February 2020 and the balance vesting in two equal annual installments thereafter, subject to the Reporting Person's continued service. The Restricted Stock Units may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]This option shall vest and become exercisable in equal monthly installments over four years commencing on February 27, 2019.